Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis

• Published in: Supportive care in cancer Vol. 29; no. 12; pp. 7461 - 7469
• Main Authors: Gu, Jialin, Lu, Hong, Chen, Chen, Gu, Zhancheng, Hu, Miao, Liu, Ling, Yu, Jialin, Wei, Guoli, Huo, Jiege
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2021; Springer; Springer Nature B.V
• Subjects: Antineoplastic Agents - adverse effects; Cancer; Carboplatin; Chemotherapy; Diabetes; Diabetes Mellitus - chemically induced; Diabetes Mellitus - epidemiology; Diabetics; Humans; Medicine; Medicine & Public Health; Meta-analysis; Nursing; Nursing Research; Odds Ratio; Oncology; Oncology, Experimental; Original; Original Article; Pain Medicine; Peripheral Nervous System Diseases - chemically induced; Peripheral Nervous System Diseases - epidemiology; Peripheral neuropathy; Rehabilitation Medicine; Risk Factors; Vincristine; China; Risk; Diabetes mellitus (DM); Chemotherapy-induced peripheral neuropathy (CIPN); Meta-analysis

Background To identify the association between diabetes mellitus (DM) and the risk of chemotherapy-induced peripheral neuropathy (CIPN) through a systematic review and meta-analysis. Methods An electronic literature search was conducted in PubMed, Embase, Web of Science, the Wanfang database, the VI...